Global Polyclonal Antibodies Market Size Study & Forecast, by Product Type (Primary Antibody, Secondary Antibody), By Application (Academic Research, Commercial) and Regional Analysis, 2023-2030

Description

List of Tables

Global Polyclonal Antibodies Market is valued at approximately USD 1054.24 million in 2022 and is anticipated to grow with a growth rate of more than 5.70% over the forecast period 2023-2030. Polyclonal antibodies are a type of antibodies that are derived from the immune response of an animal, typically a mammal, in response to the introduction of an antigen. Polyclonal antibodies are a heterogeneous mixture of antibodies produced by different B-cells, each recognizing a different epitope on the antigen. The production of polyclonal antibodies in animals necessitates the administration of the same antigen repeatedly. They are an amalgam of antibodies made by many B-cell lineages. These antibodies are a group of immunoglobulin molecules that bind to certain antigens and recognize various antigen epitopes. Inoculating a suitable mammal, like a rabbit, mouse, or goat, with a virus produces antibodies frequently. After the mammal receives the antigen, B cells produce immunoglobulin G (IgG) that is exclusive to that antigen. The market growth is anticipated to rise as a result of the progressive healthcare industry, growing neurobiology and stem cell research, and the accessibility of high-tech products.

Additionally, an increase in the incidences of infectious and chronic diseases and a rise in cancer prevalence are predicted to boost the global polyclonal antibody market. The World Cancer Research Fund International estimates that globally approximately 18.1 million new cases of cancer were recorded in 2020, in which 9.3 million of these instances involved men, while 8.8 million involved women. Furthermore, Major pharmaceutical and biotechnology businesses are also expected to expand their research and development efforts globally, creating various growth prospects for the market. Additionally, Industry leaders in the global polyclonal antibody market employ a range of strategies, including alliances, mergers and acquisitions, and collaboration, which is likely to present the industry with multiple growth opportunities . However, the market for polyclonal antibodies is expected to face challenges from factors such as the high price of research antibodies and the low purity and concentration levels of some of these antibodies throughout the forecast period of 2023-2030.

The key regions considered for the Global Polyclonal Antibodies Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the region's high concentration of top players and ongoing research & development activities. Asia-Pacific is expected to grow with the fastest CAGR over the projected period of 2023-2030. Factors such as the rising rates of cancer and other disorders, advancements in healthcare infrastructure in countries such as India, China, and South Korea, increasing demand for personalized medicine as well as the rising demand for therapeutic antibodies in the region.

Major market players included in this report are:

Thermo Fisher Scientific Inc.
Merck KGaA
Abcam plc
Bio-Rad Laboratories Inc.
Cell Signaling Technology Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Agilent Technologies
PerkinElmer Inc.
BioLegend, Inc

Recent Developments in the Market:

In October 2022, The Binding Site consortium is acquired by Thermo Fisher Scientific Inc. with USD 2.6 billion as of the time of publishing from a consortium of stockholders led by the European private equity firm Nordic Capital.

Global Polyclonal Antibodies Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Primary Antibody
Secondary Antibody

By Application:

Academic Research
Commercial

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
- 1.2.1. Polyclonal Antibodies Market, by region, 2020-2030 (USD Million)
- 1.2.2. Polyclonal Antibodies Market, by Product, 2020-2030 (USD Million)
- 1.2.3. Polyclonal Antibodies Market, by Application, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Polyclonal Antibodies Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Polyclonal Antibodies Market Dynamics

3.1. Polyclonal Antibodies Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growing healthcare industry
  - 3.1.1.2. Increased neurobiology and stem cell research
  - 3.1.1.3. Increase in the incidences of infectious and chronic diseases
- 3.1.2. Market Challenges
  - 3.1.2.1. High cost of polyclonal antibodies
  - 3.1.2.2. Low purity and concentration levels of some of the antibodies
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing Research and Development
  - 3.1.3.2. Surging initiatives by the key market players

Chapter 4. Global Polyclonal Antibodies Market: Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Polyclonal Antibodies Market, by Product

5.1. Market Snapshot
5.2. Global Polyclonal Antibodies Market by Product, Performance - Potential Analysis
5.3. Global Polyclonal Antibodies Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Polyclonal Antibodies Market, Sub Segment Analysis
- 5.4.1. Primary Antibody
- 5.4.2. Secondary Antibody

Chapter 6. Global Polyclonal Antibodies Market, by Application

6.1. Market Snapshot
6.2. Global Polyclonal Antibodies Market by Application, Performance - Potential Analysis
6.3. Global Polyclonal Antibodies Market Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Polyclonal Antibodies Market, Sub Segment Analysis
- 6.4.1. Academic Research
- 6.4.2. Commercial

Chapter 7. Global Polyclonal Antibodies Market, Regional Analysis

7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Polyclonal Antibodies Market, Regional Market Snapshot
7.4. North America Polyclonal Antibodies Market
- 7.4.1. U.S. Polyclonal Antibodies Market
  - 7.4.1.1. Product breakdown estimates & forecasts, 2020-2030
  - 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
- 7.4.2. Canada Polyclonal Antibodies Market
7.5. Europe Polyclonal Antibodies Market Snapshot
- 7.5.1. U.K. Polyclonal Antibodies Market
- 7.5.2. Germany Polyclonal Antibodies Market
- 7.5.3. France Polyclonal Antibodies Market
- 7.5.4. Spain Polyclonal Antibodies Market
- 7.5.5. Italy Polyclonal Antibodies Market
- 7.5.6. Rest of Europe Polyclonal Antibodies Market
7.6. Asia-Pacific Polyclonal Antibodies Market Snapshot
- 7.6.1. China Polyclonal Antibodies Market
- 7.6.2. India Polyclonal Antibodies Market
- 7.6.3. Japan Polyclonal Antibodies Market
- 7.6.4. Australia Polyclonal Antibodies Market
- 7.6.5. South Korea Polyclonal Antibodies Market
- 7.6.6. Rest of Asia Pacific Polyclonal Antibodies Market
7.7. Latin America Polyclonal Antibodies Market Snapshot
- 7.7.1. Brazil Polyclonal Antibodies Market
- 7.7.2. Mexico Polyclonal Antibodies Market
7.8. Middle East & Africa Polyclonal Antibodies Market
- 7.8.1. Saudi Arabia Polyclonal Antibodies Market
- 7.8.2. South Africa Polyclonal Antibodies Market
- 7.8.3. Rest of Middle East & Africa Polyclonal Antibodies Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Company 1
- 8.1.2. Company 2
- 8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Thermo Fisher Scientific Inc.
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Recent Developments
- 8.3.2. Merck KGaA
- 8.3.3. Abcam plc
- 8.3.4. Bio-Rad Laboratories Inc.
- 8.3.5. Cell Signaling Technology Inc.
- 8.3.6. F. Hoffmann-La Roche Ltd.
- 8.3.7. Danaher Corporation
- 8.3.8. Agilent Technologies
- 8.3.9. PerkinElmer Inc.
- 8.3.10. BioLegend, Inc

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Polyclonal Antibodies Market, report scope
TABLE 2. Global Polyclonal Antibodies Market estimates & forecasts by region 2020-2030 (USD Million)
TABLE 3. Global Polyclonal Antibodies Market estimates & forecasts by Product 2020-2030 (USD Million)
TABLE 4. Global Polyclonal Antibodies Market estimates & forecasts by Application 2020-2030 (USD Million)
TABLE 5. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 6. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Polyclonal Antibodies Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Polyclonal Antibodies Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. U.S. Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 17. U.S. Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. Canada Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. Canada Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. UK Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. UK Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. Germany Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. Germany Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. France Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. France Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. Italy Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. Italy Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Spain Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Spain Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. RoE Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. RoE Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. China Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. China Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. India Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. India Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. Japan Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. Japan Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. South Korea Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. South Korea Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. Australia Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. Australia Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. RoAPAC Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. RoAPAC Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. Brazil Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. Brazil Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Mexico Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Mexico Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. RoLA Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. RoLA Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. Saudi Arabia Polyclonal Antibodies Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. South Africa Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoMEA Polyclonal Antibodies Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Polyclonal Antibodies Market
TABLE 70. List of primary sources, used in the study of global Polyclonal Antibodies Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Polyclonal Antibodies Market, research methodology
FIG 2. Global Polyclonal Antibodies Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Polyclonal Antibodies Market, key trends 2022
FIG 5. Global Polyclonal Antibodies Market, growth prospects 2023-2030
FIG 6. Global Polyclonal Antibodies Market, porters 5 force model
FIG 7. Global Polyclonal Antibodies Market, pest analysis
FIG 8. Global Polyclonal Antibodies Market, value chain analysis
FIG 9. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Polyclonal Antibodies Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Polyclonal Antibodies Market, regional snapshot 2020 & 2030
FIG 15. North America Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 16. Europe Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 18. Latin America Polyclonal Antibodies Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Polyclonal Antibodies Market 2020 & 2030 (USD Million)